Fluticasone propionate/Salmeterol (FSC) 250/50 mcg
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Fluticasone propionate/Salmeterol (FSC) 250/50 mcg, covering 2015-10-08 to 2015-10-08. Get the full timeline:
Most recent: Clinical Trial Update: A Non-inferiority Study to Evaluate the Efficacy, Safety, and Tolerability of Combination Dry Powder of Fluticasone Propionate and Salmeterol (FSC) 250/50 Microgram (mcg) Twice Daily (BID) in Adults and Adolescents With Asthma [Phase 3]